Ferru Emanuela, Pantaleo Antonella, Carta Franco, Mannu Franca, Khadjavi Amina, Gallo Valentina, Ronzoni Luisa, Graziadei Giovanna, Cappellini Maria Domenica, Turrini Francesco
Haematologica. 2014 Mar;99(3):570-8. doi: 10.3324/haematol.2013.084533. Epub 2013 Sep 13.
High counts of circulating microparticles, originated from the membrane of abnormal erythrocytes, have been associated with increased thrombotic risk in hemolytic disorders. Our studies indicate that in thalassemia intermedia patients the number of circulating microparticles correlates with the capability of the thalassemic erythrocytes to release microparticles. The microparticles are characteristically loaded with hemichromes formed by denatured α-chains. This finding was substantiated by the positive correlation observed in thalassemia intermedia patients between the amount of hemichromes measured in erythrocytes, their capability to release microparticles and the levels of plasma hemichromes. We observed that hemichromes, following their binding to the cytoplasmic domain of band 3, induce the formation of disulfide band 3 dimers that are subsequently phosphorylated by p72Syk kinase. Phosphorylation of oxidized band 3 appears to be relevant for the formation of large hemichromes/band 3 clusters that, in turn, induce local membrane instability and the release of microparticles. Proteomic analysis of microparticles released from thalassemia intermedia erythrocytes indicated that, besides hemichromes and clustered band 3, the microparticles contain a characteristic set of proteins that includes catalase, heat shock protein 70, peroxiredoxin 2 and carbonic anhydrase. High amounts of immunoglobulins and C3 have also been found to be associated with microparticles, accounting for their intense phagocytosis. The effect of p72Syk kinase inhibitors on the release of microparticles from thalassemia intermedia erythrocytes may indicate new perspectives for controlling the release of circulating microparticles in hemolytic anemias.
源自异常红细胞膜的循环微颗粒数量增多,与溶血性疾病中血栓形成风险增加有关。我们的研究表明,中间型地中海贫血患者循环微颗粒的数量与地中海贫血红细胞释放微颗粒的能力相关。这些微颗粒的特征是负载有由变性α链形成的高铁血红素。中间型地中海贫血患者红细胞中测得的高铁血红素量、其释放微颗粒的能力与血浆高铁血红素水平之间存在正相关,这一发现证实了上述结论。我们观察到,高铁血红素与带3的细胞质结构域结合后,会诱导二硫键连接的带3二聚体形成,随后被p72Syk激酶磷酸化。氧化型带3的磷酸化似乎与大型高铁血红素/带3簇的形成有关,进而诱导局部膜不稳定和微颗粒释放。对中间型地中海贫血红细胞释放的微颗粒进行蛋白质组分析表明,除了高铁血红素和聚集的带3外,这些微颗粒还含有一组特征性蛋白质,包括过氧化氢酶、热休克蛋白70、过氧化物酶2和碳酸酐酶。还发现大量免疫球蛋白和C3与微颗粒有关,这解释了它们强烈的吞噬作用。p72Syk激酶抑制剂对中间型地中海贫血红细胞微颗粒释放的影响可能为控制溶血性贫血中循环微颗粒的释放指明新的方向。